Online inquiry

IVTScrip™ mRNA-Human ADARB1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A))   (CAT#: GTTS-WK10413MR)

This product GTTS-WK10413MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP. It ecodes the ADARB1 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP
5' Cap Cap 0
Species Human
RefSeq NM_001112.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 104
UniProt ID P78563
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADARB1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) (GTTS-WK10413MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK5240MR IVTScrip™ mRNA-Human CRYL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA CRYL1
GTTS-WK14853MR IVTScrip™ mRNA-Human Aminopeptidase-N, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Aminopeptidase-N
GTTS-WK10946MR IVTScrip™ mRNA-Human ACSL1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ACSL1
GTTS-WK20253MR IVTScrip™ mRNA-Human Aminopeptidase-N, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Aminopeptidase-N
GTTS-WK9424MR IVTScrip™ mRNA-Human Acetylcholinesterase, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Acetylcholinesterase
GTTS-WK2773MR IVTScrip™ mRNA-Human CD309, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA CD309
GTTS-WK11237MR IVTScrip™ mRNA-Human ACOX1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACOX1
GTTS-WK3245MR IVTScrip™ mRNA-Human CD10, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA CD10
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →